middle.news
How Is Apiam’s Strategic Reset Driving a 40% EBITDA Surge Amid Acquisition Talks?
8:44am on Thursday 20th of November, 2025 AEDT
•
Healthcare
Read Story
How Is Apiam’s Strategic Reset Driving a 40% EBITDA Surge Amid Acquisition Talks?
8:44am on Thursday 20th of November, 2025 AEDT
Key Points
FY25 revenue growth modest at 1.4%, impacted by Clinical Vet Services decline
Strategic Reset Program launched under new Interim MD Bruce Dixon
Q1 FY26 revenue up 3.3%, EBITDA surges 40% following cost reductions
Binding Scheme Implementation Deed with Adamantem Capital at $0.87/share
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Apiam Animal Health (ASX:AHX)
OPEN ARTICLE